article thumbnail

Amgen Completes Onyx Pharmaceuticals Tender Offer

socalTECH

Thousand Oaks-based Amgen reported this morning that it has completed its tender offer for Onyx Pharmaceuticals , and now expects its acquisition to complete today. onyx pharmaceuticals amgen merger acquisition biotech lifescience cancer' Amgen said the deal is worth $9.7 billion net of estimated cash at Onyx.

article thumbnail

Ceres Delays IPO

socalTECH

Thousand Oaks-based Ceres has delayed its IPO, after lowering its IPO pricing estimates this week. According to industry reports , Ceres is delaying the offering until next week. Ceres had initially planned to price its IPO on Thursday. READ MORE>>.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nexsan Updates S-1

socalTECH

In a sign that Thousand Oaks-based Nexsan might be ramping up its IPO efforts again, after a delay last year, the firm filed an updated S-1 this week. The provider of data storage equipment reported that it had net income of $0.5M The provider of data storage equipment reported that it had net income of $0.5M

article thumbnail

Nexsan Names Sales Head

socalTECH

Thousand Oaks-based Nexsan, a developer of storage hardware products, has appointed a new Chief Commercial Officer, the firm disclosed Monday. Nexsan said that Michael McGuire has joined the firm, reporting to CEO Philip Black, and will be in charge of worldwide sales, marketing, and business development. READ MORE>>

Sales 100
article thumbnail

Will Facebook's IPO Unbottle Southern California's Pipeline?

socalTECH

The firm reported net income of $1 billion on revenues of $3.7 Will the filing of an IPO by Menlo Park-based Facebook unclock the pipeline of would-be Southern Calfornia IPOs? Facebook filed for its IPO Wednesday afternoon, saying that it is looking to raise up to $5 billion, in what is expected to be the biggest IPO since Google.